Meeting
2016 ASCO Annual Meeting
NCI-MATCH (Molecular Analysis for Therapy Choice) – a national signal finding trial.
Authors
Barbara A. Conley
National Cancer Institute, Rockville, MD
Barbara A. Conley , Alice P. Chen , Peter J. O'Dwyer , Carlos L. Arteaga , Stanley R. Hamilton , Paul M. Williams , Richard F. Little , Naoko Takebe , David Patton , Kamalia Sazali , Jeffrey Zhang , James A. Zwiebel , Edith P. Mitchell , Robert James Gray , Lisa McShane , Shuli Li , Larry Rubinstein , Keith Flaherty
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Clinical Pharmacology and Experimental Therapeutics
Track
Developmental Therapeutics and Translational Research
Sub Track
Small Molecules
Clinical Trial Registration Number
NCT02465060
Citation
J Clin Oncol 34, 2016 (suppl; abstr TPS2606)
DOI
10.1200/JCO.2016.34.15_suppl.TPS2606
Abstract #
TPS2606
Poster Bd #
298b
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
Impact of next-generation sequencing (NGS) on treatment decisions in the community oncology setting.
First Author: Lindsay Carol Overton
Poster
2018 ASCO Annual Meeting
Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.
First Author: Razelle Kurzrock
Poster
2017 ASCO Annual Meeting
The scope of possible combination therapy with immunotherapy and targeted therapy.
First Author: Leandro Machado Colli
Poster
2015 ASCO Annual Meeting
Migration to next-generation sequencing and the identification of RET and ROS1 rearrangements plus PTEN and MET protein expression in tumor specimens from patients with lung adenocarcinomas: Lung Cancer Mutation Consortium (LCMC 2.0).
First Author: Mark G. Kris